Drug General Information (ID: DDIO6Q2WUV)
Drug Name			Tolterodine		Drug Info		Mirabegron		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antispasmodics				Urinary Antispasmodics
Structure

Mechanism of Tolterodine-Mirabegron Interaction (Severity Level: Moderate)
Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph
Drug Name		Tolterodine				Mirabegron
Mechanism		Urinary retention				Urinary retention
Key Mechanism Factor 1
		Factor Name		Adverse reactions
		Factor Description		An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly.
Mechanism Description		Increased risk of adverse reactions by the combination of Tolterodine and Mirabegron

Recommended Action
Management		Caution is advised if mirabegron is prescribed in combination with antimuscarinic medications used for the treatment of overactive bladder.

References
1	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.